KPW
IMRX icon

Kore Private Wealth’s Immuneering IMRX Stock Holding History

Kore Private Wealth’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$840K Sell
58,649
-375
-0.6% -$2.98K 0.15% 95
2022
Q2 		$319K Hold
59,024
– – 0.05% 207
2022
Q1 		$382K Buy
59,024
+40,924
+226% +$393K 0.05% 207
2021
Q4 		$293K Buy
18,100
+4,000
+28% +$97.3K 0.04% 244
2021
Q3 		$374K Buy
+14,100
New +$379K 0.04% 285

Other funds holding IMRX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BSW
Buckingham Strategic Wealth Clayton, Missouri $9.66B AUM 15.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Kore Private Wealth's IMRX Position: Q3 2022 in Review

Kore Private Wealth reduced its Immuneering (IMRX) stake by 0.64% in Q3 2022, selling an estimated $2.98K and leaving 58,649 shares worth $840K. The position accounts for 0.15% of the portfolio, ranked #95.

Kore Private Wealth first reported a position in IMRX in Q3 2021 and has held it in 5 quarters since. 32 funds tracked by Wall St. Rank hold IMRX as of Q3 2022.

  • Kore Private Wealth held 58,649 shares of Immuneering worth $840K as of Q3 2022.
  • Kore Private Wealth sold 375 Immuneering shares in Q3 2022, an estimated $2.98K.
  • Immuneering made up 0.15% of Kore Private Wealth's portfolio in Q3 2022, its #95 holding.
  • Kore Private Wealth first reported a position in Immuneering in Q3 2021 and has held it in 5 quarters since.
  • 32 funds tracked by Wall St. Rank held Immuneering as of Q3 2022.

Based on Kore Private Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.